Continuous intravenous versus intermittent bolus midazolam with remifentanil during arteriovenous fistula placement with monitored anesthesia care in chronic renal failure patients: a randomized controlled trial.

ABSTRACT:

Background

There is limited data on the use of intravenous continuous infusion (CI) versus intravenous intermittent bolus (IB) doses of midazolam for conscious sedation in patients with chronic renal failure. Unexpected adverse events can occur in chronic renal failure patients undergoing short procedures.

Objective

Investigate and compare the sedoanalgesic and adverse effects of intravenous continuous infusion (CI) use of midazolam with intravenous intermittent bolus (IB) doses of midazolam while using intravenous remifentanil as a rescue medication, and assess patient and surgeon satisfaction.

Design

Prospective, randomized, single-blind controlled study.

Settings

Two tertiary care hospitals.

Patients and methods

Study included patients aged 43-81 year

SUBMITTER: Sagiroglu G 

PROVIDER: S-EPMC7270617 | biostudies-literature | 2020 May-Jun

REPOSITORIES: biostudies-literature